Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""formation"" wg kryterium: Temat


Tytuł :
Probabilistic Atlas of the Mesencephalic Reticular Formation, Isthmic Reticular Formation, Microcellular Tegmental Nucleus, Ventral Tegmental Area Nucleus Complex, and Caudal-Rostral Linear Raphe Nucleus Complex in Living Humans from 7 Tesla Magnetic Resonance Imaging.
Autorzy :
Singh K; Brainstem Imaging Laboratory, Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
García-Gomar MG; Brainstem Imaging Laboratory, Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Bianciardi M; Brainstem Imaging Laboratory, Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Brain connectivity [Brain Connect] 2021 Oct; Vol. 11 (8), pp. 613-623. Date of Electronic Publication: 2021 Jun 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain*
Midbrain Reticular Formation*
Humans ; Magnetic Resonance Imaging ; Raphe Nuclei ; Reticular Formation ; Tegmentum Mesencephali
Czasopismo naukowe
Tytuł :
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
Autorzy :
Law JC; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Girard M; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Chao GYC; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Ward LA; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Isho B; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Rathod B; Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
Colwill K; Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
Li Z; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Rini JM; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Yue FY; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Mubareka S; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Research Institute, Toronto, Ontario, Canada; and.
McGeer AJ; Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Ostrowski MA; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, UnityHealth, Toronto, Ontario, Canada.
Gommerman JL; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Gingras AC; Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Watts TH; Department of Immunology, University of Toronto, Toronto, Ontario, Canada; .
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Jan 15; Vol. 208 (2), pp. 429-443. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Immunity, Cellular*
COVID-19/*immunology
Immunoglobulin G/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Th1 Cells/*immunology
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Time Factors
Czasopismo naukowe
Tytuł :
Patterns of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Among 1.6 Million Blood Donors: Impact of Vaccination, United States, December 2020-June 2021.
Autorzy :
Dodd RY; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.
Notari EP; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.
Brodsky JP; Quality Analytics, Deerfield, Illinois, USA.
Foster GA; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.
Xu M; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.
Saá P; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.
Stramer SL; American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2022 Jan 05; Vol. 225 (1), pp. 5-9.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Blood Donors*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
SARS-CoV-2/*isolation & purification
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/epidemiology ; COVID-19 Testing ; Female ; Humans ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Spike Glycoprotein, Coronavirus ; United States/epidemiology ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.
Autorzy :
Baptista BO; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil.
de Souza ABL; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil.
Riccio EKP; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil.
Bianco-Junior C; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil.
Totino PRR; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil.
Martins da Silva JH; Departamento de Bioinformática, Fiocruz, Ceará, Brazil.
Theisen M; Centre for Medical Parasitology at Department of International Health, Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Singh SK; Centre for Medical Parasitology at Department of International Health, Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Amoah LE; Immunology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Ribeiro-Alves M; Laboratório de Pesquisa Clínica em DST e AIDS, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
Souza RM; Laboratório de Doenças Infecciosas na Amazônia Ocidental, Universidade Federal do Acre, Acre, Brazil.
Lima-Junior JC; Laboratório de Imunoparasitologia, IOC, Rio de Janeiro, Fiocruz, Brazil.
Daniel-Ribeiro CT; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil.
Pratt-Riccio LR; Laboratório de Pesquisa em Malária, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil. .; Centro de Pesquisa, Diagnóstico e Treinamento em Malária, Fiocruz, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil. .
Pokaż więcej
Źródło :
Malaria journal [Malar J] 2022 Jan 04; Vol. 21 (1), pp. 6. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Antigens, Protozoan/*immunology
Malaria Vaccines/*immunology
Membrane Glycoproteins/*immunology
Peptide Fragments/*immunology
Plasmodium falciparum/*immunology
Protozoan Proteins/*immunology
Adolescent ; Adult ; Brazil ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Panproteome Analysis of the Human Antibody Response to Bacterial Vaccines and Challenge.
Autorzy :
Campo JJ; Antigen Discovery, Inc., Irvine, CA, USA. .
Oberai A; Antigen Discovery, Inc., Irvine, CA, USA.
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2414, pp. 75-96.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Protein Array Analysis*
Bacterial Vaccines ; Humans ; Immunoglobulins ; Proteome ; Vaccination
Czasopismo naukowe
Tytuł :
The Importance of Cellular Immune Response to HIV: Implications for Antibody Production and Vaccine Design.
Autorzy :
Brenna E; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
McMichael AJ; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło :
DNA and cell biology [DNA Cell Biol] 2022 Jan; Vol. 41 (1), pp. 38-42. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
HIV-1*
Czasopismo naukowe
Tytuł :
'A small person that we made' - Parental conceptualisation of the unborn child: A constructivist grounded theory.
Autorzy :
Borg Cunen N; Department of Midwifery, Faculty of Health Sciences, University of Malta, Msida, MSD 2080, Malta. Electronic address: .
Jomeen J; School of Health and Human Sciences, Southern Cross University, Gold Coast Campus, Southern Cross Drive, Bilinga Qld. 4225, Australia.
Poat A; Department of Midwifery and Child Health, Faculty of Health and Social Care, University of Hull, HU6 7RX, UK.
Borg Xuereb R; Department of Midwifery, Faculty of Health Sciences, University of Malta, Msida, MSD 2080, Malta.
Pokaż więcej
Źródło :
Midwifery [Midwifery] 2022 Jan; Vol. 104, pp. 103198. Date of Electronic Publication: 2021 Oct 30.
Typ publikacji :
Journal Article
MeSH Terms :
Concept Formation*
Midwifery*
Child ; Emotions ; Female ; Grounded Theory ; Humans ; Male ; Parents ; Pregnancy
Czasopismo naukowe
Tytuł :
Assessing In Vivo T Cell-Dependent Antigen-Specific Antibody Responses.
Autorzy :
Xie MM; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Immunology Discovery, Genentech, Inc., South San Francisco, CA, USA.
Dent AL; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2380, pp. 165-174.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Animals ; Antigens ; Enzyme-Linked Immunosorbent Assay ; Immunoglobulin E ; Mice ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
Autorzy :
Berendam SJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Morgan-Asiedu PK; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Mangan RJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Li SH; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Heimsath H; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Luo K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Curtis AD 2nd; Department of Microbiology and Immunology, Children's Research Institute and Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Eudailey JA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell College of Medicine, New York City, New York, United States of America.
Fox CB; Infectious Disease Research Institute (IDRI), Seattle, Washington State, United States of America.; Department of Global Health, University of Washington, Seattle, Washington State, United States of America.
Tomai MA; 3M Center, 3 M Drug Delivery Systems, St. Paul, Minnesota, United States of America.
Phillips B; Department of Microbiology and Immunology, Children's Research Institute and Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Itell HL; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Kunz E; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Hudgens M; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Cronin K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Alam SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Van Rompay KKA; California National Primate Research Center, University of California at Davis, Davis, California, United States of America.
De Paris K; Department of Microbiology and Immunology, Children's Research Institute and Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Permar SR; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell College of Medicine, New York City, New York, United States of America.
Moody MA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Fouda GG; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Dec 31; Vol. 16 (12), pp. e0256885. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
AIDS Vaccines/*blood
AIDS Vaccines/*immunology
Adjuvants, Immunologic/*pharmacology
Antibody Formation/*immunology
Receptors, Antigen, B-Cell/*metabolism
env Gene Products, Human Immunodeficiency Virus/*immunology
Animals ; Antibody Formation/drug effects ; Child ; Complementarity Determining Regions ; Epitopes/immunology ; Humans ; Immunization ; Immunoglobulin Heavy Chains/metabolism ; Immunologic Memory/drug effects ; Macaca mulatta ; Somatic Hypermutation, Immunoglobulin ; Toll-Like Receptors/agonists ; Toll-Like Receptors/metabolism
Czasopismo naukowe
Tytuł :
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
Autorzy :
Montoya JG; Dr. Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Adams AE; Palo Alto Foundation Medical Group, Palo Alto, California, USA.
Bonetti V; Dr. Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Deng S; Center for Health Systems Research, Sutter Health, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Link NA; Palo Alto Foundation Medical Group, Palo Alto, California, USA.
Pertsch S; Palo Alto Foundation Medical Group, Palo Alto, California, USA.
Olson K; Dr. Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Li M; Center for Health Systems Research, Sutter Health, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Dillon EC; Center for Health Systems Research, Sutter Health, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Frosch DL; Center for Health Systems Research, Sutter Health, Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Pokaż więcej
Źródło :
Microbiology spectrum [Microbiol Spectr] 2021 Dec 22; Vol. 9 (3), pp. e0116221. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
2019-nCoV Vaccine mRNA-1273/*immunology
Antibodies, Viral/*immunology
BNT162 Vaccine/*immunology
Immunogenicity, Vaccine/*immunology
Adult ; Aged ; COVID-19 Vaccines/immunology ; Cohort Studies ; Female ; Humans ; Immunoglobulin G ; Male ; Middle Aged ; Prospective Studies ; Spike Glycoprotein, Coronavirus ; Time Factors ; Vaccination ; mRNA Vaccines/immunology
Czasopismo naukowe
Tytuł :
Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications.
Autorzy :
Volkov M; Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. .
Kampstra ASB; Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
van Schie KA; Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
Kawakami A; Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Tamai M; Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Kawashiri S; Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Maeda T; Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Huizinga TWJ; Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
Toes REM; Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
van der Woude D; Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
Pokaż więcej
Źródło :
Arthritis research & therapy [Arthritis Res Ther] 2021 Dec 08; Vol. 23 (1), pp. 298. Date of Electronic Publication: 2021 Dec 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Autoantigens*/metabolism
Animals ; Anti-Citrullinated Protein Antibodies ; Autoantibodies ; Humans ; Mice ; Protein Processing, Post-Translational
Czasopismo naukowe
Tytuł :
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study.
Autorzy :
Buonfrate D; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy. Electronic address: .
Piubelli C; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Gobbi F; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Martini D; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Bertoli G; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Ursini T; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Moro L; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Ronzoni N; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Angheben A; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Rodari P; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Cardellino C; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Tamarozzi F; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Tais S; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Rizzi E; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Degani M; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Deiana M; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Prato M; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Silva R; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Bisoffi Z; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Dec; Vol. 27 (12), pp. 1845-1850. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
COVID-19*/prevention & control
Antibodies, Viral/*blood
BNT162 Vaccine/*immunology
Health Personnel ; Humans ; Immunoglobulin G/blood ; Prospective Studies ; RNA, Messenger
Czasopismo naukowe
Tytuł :
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.
Autorzy :
Kageyama T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan.
Ikeda K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan.
Tanaka S; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan.
Taniguchi T; Department of Infectious Diseases, Chiba University Hospital, Japan.
Igari H; Department of Infectious Diseases, Chiba University Hospital, Japan; Chiba University Hospital COVID-19 Vaccine Center, Japan.
Onouchi Y; Department of Public Health, Graduate School of Medicine, Japan.
Kaneda A; Department of Molecular Oncology, Graduate School of Medicine, Japan.
Matsushita K; Division of Laboratory Medicine, Chiba University Hospital, Japan.
Hanaoka H; Clinical Research Centre, Chiba University Hospital, Japan.
Nakada TA; Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Japan.
Ohtori S; Department of Orthopaedic Surgery, Graduate School of Medicine, Japan.
Yoshino I; Department of General Thoracic Surgery, Graduate School of Medicine, Japan.
Matsubara H; Department of Frontier Surgery, Graduate School of Medicine, Japan.
Nakayama T; Department of Immunology, Graduate School of Medicine, Japan.
Yokote K; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: .
Nakajima H; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan; Chiba University Hospital COVID-19 Vaccine Center, Japan. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Dec; Vol. 27 (12), pp. 1861.e1-1861.e5. Date of Electronic Publication: 2021 Aug 08.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
COVID-19*/prevention & control
Health Personnel*
BNT162 Vaccine/*immunology
Adult ; Antibodies, Viral/blood ; Female ; Humans ; Japan ; Male ; Tertiary Care Centers
Czasopismo naukowe
Tytuł :
Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
Autorzy :
Cucunawangsih C; Department of Microbiology, Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia. Electronic address: .
Wijaya RS; Department of Microbiology, Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia.
Lugito NPH; Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia.
Suriapranata I; Division of Immunology, Mochtar Riady Institute for Nanotechnology and Medical Science Group, Pelita Harapan University, Tangerang, Indonesia.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Dec; Vol. 113, pp. 15-17. Date of Electronic Publication: 2021 Oct 03.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
COVID-19*
COVID-19 Vaccines ; Health Personnel ; Humans ; Indonesia ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
The intuitive conceptualization and perception of variance.
Autorzy :
Konovalova E; Warwick Business School, University of Warwick, Coventry CV4 7AL, United Kingdom; Center for Adaptive Rationality, Max Planck Institute for Human Development, Lentzeallee 94, 14195 Berlin, Germany. Electronic address: .
Pachur T; Center for Adaptive Rationality, Max Planck Institute for Human Development, Lentzeallee 94, 14195 Berlin, Germany.
Pokaż więcej
Źródło :
Cognition [Cognition] 2021 Dec; Vol. 217, pp. 104906. Date of Electronic Publication: 2021 Sep 25.
Typ publikacji :
Journal Article
MeSH Terms :
Concept Formation*
Judgment*
Humans ; Models, Psychological ; Perception
Czasopismo naukowe
Tytuł :
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Autorzy :
Alejo JL; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Mitchell J; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Chiang TP; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Abedon AT; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Boyarsky BJ; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Avery RK; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.
Tobian AAR; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Levan ML; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Massie AB; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Garonzik-Wang JM; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Segev DL; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Werbel WA; Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Dec 01; Vol. 105 (12), pp. e280-e281.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
COVID-19*/prevention & control
Transplant Recipients*
COVID-19 Vaccines/*immunology
Humans ; Organ Transplantation
Czasopismo naukowe
Tytuł :
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh.
Autorzy :
Jamiruddin R; Department of Pharmacy, Brac University, Dhaka, Bangladesh.; Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhanmondi, Dhaka, Bangladesh.
Haq A; Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhanmondi, Dhaka, Bangladesh.
Khondoker MU; Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhanmondi, Dhaka, Bangladesh.; Department of Community Medicine, Gonoshasthaya Samaj Vittik Medical College, Savar, Dhaka, Bangladesh.
Ali T; Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhanmondi, Dhaka, Bangladesh.
Ahmed F Md; Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Khandker SS; Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhanmondi, Dhaka, Bangladesh.
Jawad I; Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Hossain R; Department of Microbiology, Gono Bishwabidyalay, Savar, Dhaka, Bangladesh.
Ahmed S; Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Rahman SR; Department of Microbiology, University of Dhaka, Dhaka, Bangladesh.
Mustafi M; Department of Community Medicine, Gonoshasthaya Samaj Vittik Medical College, Savar, Dhaka, Bangladesh.
Kaitsuka T; Department of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare, Okawa, Fukuoka, Japan.
Mie M; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, Japan.
Tomizawa K; Department of Molecular Physiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kobatake E; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, Japan.
Haque M; The Unit of Pharmacology, Faculty of Medicine and Defence Health Universiti Pertahanan, Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sugai Besi, Kuala Lumpur, Malaysia.
Adnan N; Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhanmondi, Dhaka, Bangladesh.; Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Pokaż więcej
Źródło :
Expert review of vaccines [Expert Rev Vaccines] 2021 Dec; Vol. 20 (12), pp. 1651-1660. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
COVID-19*
Antibodies, Viral/*blood
COVID-19 Vaccines/*immunology
Bangladesh ; ChAdOx1 nCoV-19 ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Immunoglobulin M/blood
Czasopismo naukowe
Tytuł :
Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents.
Autorzy :
Breznik JA; McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Zhang A; McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada; Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Huynh A; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Miller MS; McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada; Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Nazy I; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; McMaster Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada.
Bowdish DME; McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Firestone Institute of Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada. Electronic address: .
Costa AP; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; Centre for Integrated Care, St. Joseph's Health System, Hamilton, ON, Canada.
Pokaż więcej
Źródło :
Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2021 Dec; Vol. 22 (12), pp. 2512-2514. Date of Electronic Publication: 2021 Nov 01.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Vaccination*
2019-nCoV Vaccine mRNA-1273/*administration & dosage
BNT162 Vaccine/*administration & dosage
COVID-19/*prevention & control
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Nursing Homes ; Ontario
Raport
Tytuł :
Conceptualizations of Cyberchondria and Relations to the Anxiety Spectrum: Systematic Review and Meta-analysis.
Autorzy :
Schenkel SK; Department of Clinical Psychology, Psychotherapy, and Experimental Psychopathology, Johannes Gutenberg-University Mainz, Mainz, Germany.
Jungmann SM; Department of Clinical Psychology, Psychotherapy, and Experimental Psychopathology, Johannes Gutenberg-University Mainz, Mainz, Germany.
Gropalis M; Department of Clinical Psychology, Psychotherapy, and Experimental Psychopathology, Johannes Gutenberg-University Mainz, Mainz, Germany.
Witthöft M; Department of Clinical Psychology, Psychotherapy, and Experimental Psychopathology, Johannes Gutenberg-University Mainz, Mainz, Germany.
Pokaż więcej
Źródło :
Journal of medical Internet research [J Med Internet Res] 2021 Nov 18; Vol. 23 (11), pp. e27835. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Concept Formation*
Hypochondriasis*
Anxiety ; Anxiety Disorders ; Humans ; Internet ; Uncertainty
Czasopismo naukowe
Tytuł :
Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes.
Autorzy :
Hedberg P; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Sirel M; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden.
Moll K; Department of Medicine, Huddinge, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Kiwuwa MS; Department of Child Health and Development Centre, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Höglund P; Department of Medicine, Huddinge, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Ribacke U; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden.
Wahlgren M; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden. .
Pokaż więcej
Źródło :
Malaria journal [Malar J] 2021 Nov 18; Vol. 20 (1), pp. 441. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
MeSH Terms :
Rosette Formation*
ABO Blood-Group System/*immunology
Antibodies, Protozoan/*immunology
Heparin/*immunology
Protozoan Proteins/*immunology
ABO Blood-Group System/genetics ; Flow Cytometry ; Gene Frequency ; Human Genome Project ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies